Your browser doesn't support javascript.
loading
Genome-wide analyses identify 21 infertility loci and over 400 reproductive hormone loci across the allele frequency spectrum.
Venkatesh, Samvida S; Wittemans, Laura B L; Palmer, Duncan S; Baya, Nikolas A; Ferreira, Teresa; Hill, Barney; Lassen, Frederik Heymann; Parker, Melody J; Reibe, Saskia; Elhakeem, Ahmed; Banasik, Karina; Bruun, Mie T; Erikstrup, Christian; Jensen, Bitten A; Juul, Anders; Mikkelsen, Christina; Nielsen, Henriette S; Ostrowski, Sisse R; Pedersen, Ole B; Rohde, Palle D; Sorensen, Erik; Ullum, Henrik; Westergaard, David; Haraldsson, Asgeir; Holm, Hilma; Jonsdottir, Ingileif; Olafsson, Isleifur; Steingrimsdottir, Thora; Steinthorsdottir, Valgerdur; Thorleifsson, Gudmar; Figueredo, Jessica; Karjalainen, Minna K; Pasanen, Anu; Jacobs, Benjamin M; Hubers, Nikki; Lippincott, Margaret; Fraser, Abigail; Lawlor, Deborah A; Timpson, Nicholas J; Nyegaard, Mette; Stefansson, Kari; Magi, Reedik; Laivuori, Hannele; van Heel, David A; Boomsma, Dorret I; Balasubramanian, Ravikumar; Seminara, Stephanie B; Chan, Yee-Ming; Laisk, Triin; Lindgren, Cecilia M.
Afiliação
  • Venkatesh SS; Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, University of Oxford, Oxford OX3 7LF, United Kingdom.
  • Wittemans LBL; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7BN, United Kingdom.
  • Palmer DS; Novo Nordisk Research Centre Oxford, Oxford, United Kingdom.
  • Baya NA; Nuffield Department of Women's and Reproductive Health, Medical Sciences Division, University of Oxford, United Kingdom.
  • Ferreira T; Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, University of Oxford, Oxford OX3 7LF, United Kingdom.
  • Hill B; Nuffield Department of Population Health, Medical Sciences Division, University of Oxford, Oxford, United Kingdom.
  • Lassen FH; Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, University of Oxford, Oxford OX3 7LF, United Kingdom.
  • Parker MJ; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7BN, United Kingdom.
  • Reibe S; Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, University of Oxford, Oxford OX3 7LF, United Kingdom.
  • Elhakeem A; Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, University of Oxford, Oxford OX3 7LF, United Kingdom.
  • Banasik K; Nuffield Department of Population Health, Medical Sciences Division, University of Oxford, Oxford, United Kingdom.
  • Bruun MT; Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, University of Oxford, Oxford OX3 7LF, United Kingdom.
  • Erikstrup C; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7BN, United Kingdom.
  • Jensen BA; Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, University of Oxford, Oxford OX3 7LF, United Kingdom.
  • Juul A; Nuffield Department of Clinical Medicine, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom.
  • Mikkelsen C; Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, University of Oxford, Oxford OX3 7LF, United Kingdom.
  • Nielsen HS; Nuffield Department of Population Health, Medical Sciences Division, University of Oxford, Oxford, United Kingdom.
  • Ostrowski SR; MRC Integrative Epidemiology Unit at the University of Bristol, Bristol, United Kingdom.
  • Pedersen OB; Population Health Science, Bristol Medical School, University of Bristol, Bristol, United Kingdom.
  • Rohde PD; Novo Nordisk Foundation Center for Protein Research, University of Copenhagen, Copenhagen, Denmark.
  • Sorensen E; Department of Obstetrics and Gynecology, Copenhagen University Hospital, Hvidovre, Copenhagen, Denmark.
  • Ullum H; Department of Clinical Immunology, Odense University Hospital, Odense, Denmark.
  • Westergaard D; Department of Clinical Immunology, Aarhus University Hospital, Aarhus, Denmark.
  • Haraldsson A; Department of Clinical Medicine, Health, Aarhus University, Aarhus, Denmark.
  • Holm H; Department of Clinical Immunology, Aalborg University Hospital, Aalborg, Denmark.
  • Jonsdottir I; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen; Copenhagen, Denmark.
  • Olafsson I; Department of Growth and Reproduction, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark.
  • Steingrimsdottir T; Department of Clinical Immunology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
  • Steinthorsdottir V; Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Science, Copenhagen University, Copenhagen, Denmark.
  • Thorleifsson G; Department of Obstetrics and Gynecology, The Fertility Clinic, Hvidovre University Hospital, Copenhagen, Denmark.
  • Figueredo J; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Karjalainen MK; Department of Clinical Immunology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
  • Pasanen A; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Jacobs BM; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Hubers N; Department of Clinical Immunology, Zealand University Hospital, Kge, Denmark.
  • Lippincott M; Faculty of Medicine, University of Iceland, Reykjavik, Iceland.
  • Fraser A; Children's Hospital Iceland, Landspitali University Hospital, Reykjavik, Iceland.
  • Lawlor DA; deCODE genetics/Amgen, Inc., Reykjavik, Iceland.
  • Timpson NJ; Faculty of Medicine, University of Iceland, Reykjavik, Iceland.
  • Nyegaard M; deCODE genetics/Amgen, Inc., Reykjavik, Iceland.
  • Stefansson K; Department of Clinical Biochemistry, Landspitali University Hospital, Reykjavik, Iceland.
  • Magi R; Faculty of Medicine, University of Iceland, Reykjavik, Iceland.
  • Laivuori H; Department of Obstetrics and Gynecology, Landspitali University Hospital, Reykjavik, Iceland.
  • van Heel DA; deCODE genetics/Amgen, Inc., Reykjavik, Iceland.
  • Boomsma DI; deCODE genetics/Amgen, Inc., Reykjavik, Iceland.
  • Balasubramanian R; Estonian Genome Centre, Institute of Genomics, University of Tartu, Tartu, Estonia.
  • Seminara SB; Institute for Molecular Medicine Finland, Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland.
  • Chan YM; Research Unit of Population Health, Faculty of Medicine, University of Oulu, Finland.
  • Laisk T; Northern Finland Birth Cohorts, Arctic Biobank, Infrastructure for Population Studies, Faculty of Medicine, University of Oulu, Oulu, Finland.
  • Lindgren CM; Research Unit of Clinical Medicine, Medical Research Center Oulu, University of Oulu, and Department of Children and Adolescents, Oulu University Hospital, Oulu, Finland.
medRxiv ; 2024 Mar 20.
Article em En | MEDLINE | ID: mdl-38562841
ABSTRACT
Genome-wide association studies (GWASs) may help inform treatments for infertility, whose causes remain unknown in many cases. Here we present GWAS meta-analyses across six cohorts for male and female infertility in up to 41,200 cases and 687,005 controls. We identified 21 genetic risk loci for infertility (P≤5E-08), of which 12 have not been reported for any reproductive condition. We found positive genetic correlations between endometriosis and all-cause female infertility (rg=0.585, P=8.98E-14), and between polycystic ovary syndrome and anovulatory infertility (rg=0.403, P=2.16E-03). The evolutionary persistence of female infertility-risk alleles in EBAG9 may be explained by recent directional selection. We additionally identified up to 269 genetic loci associated with follicle-stimulating hormone (FSH), luteinising hormone, oestradiol, and testosterone through sex-specific GWAS meta-analyses (N=6,095-246,862). While hormone-associated variants near FSHB and ARL14EP colocalised with signals for anovulatory infertility, we found no rg between female infertility and reproductive hormones (P>0.05). Exome sequencing analyses in the UK Biobank (N=197,340) revealed that women carrying testosterone-lowering rare variants in GPC2 were at higher risk of infertility (OR=2.63, P=1.25E-03). Taken together, our results suggest that while individual genes associated with hormone regulation may be relevant for fertility, there is limited genetic evidence for correlation between reproductive hormones and infertility at the population level. We provide the first comprehensive view of the genetic architecture of infertility across multiple diagnostic criteria in men and women, and characterise its relationship to other health conditions.

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: MedRxiv Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: MedRxiv Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Reino Unido